16.96
-0.09(-0.53%)
Currency In USD
| Previous Close | 17.05 |
| Open | 16.9 |
| Day High | 17.27 |
| Day Low | 16.85 |
| 52-Week High | 26.4 |
| 52-Week Low | 15.28 |
| Volume | 94,517 |
| Average Volume | 172,836 |
| Market Cap | 425.31M |
| PE | -8.65 |
| EPS | -1.96 |
| Moving Average 50 Days | 17.82 |
| Moving Average 200 Days | 19.37 |
| Change | -0.09 |
If you invested $1000 in OrthoPediatrics Corp. (KIDS) since IPO date, it would be worth $904.53 as of February 21, 2026 at a share price of $16.96. Whereas If you bought $1000 worth of OrthoPediatrics Corp. (KIDS) shares 5 years ago, it would be worth $300.07 as of February 21, 2026 at a share price of $16.96.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
GlobeNewswire Inc.
Feb 12, 2026 9:05 PM GMT
WARSAW, Ind., Feb. 12, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled
OrthoPediatrics Announces Expanded Enabling Technology Market Opportunity
GlobeNewswire Inc.
Feb 03, 2026 12:05 PM GMT
OrthoPediatrics partner iotaMotion receives FDA clearance for use of its iotaSOFT® cochlear implant insertion system in patients four years and olderWARSAW, Ind., Feb. 03, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Co
OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance
GlobeNewswire Inc.
Jan 12, 2026 12:05 PM GMT
Achieves all-time high full year 2025 Revenue of $236.1 million representing growth of 15% over prior yearInitiates guidance for record Adjusted EBITDA in 2026 WARSAW, Ind., Jan. 12, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”